1. GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes. (6th January 2020) Authors: Pavo, Noemi; Wurm, Raphael; Neuhold, Stephanie; Adlbrecht, Christopher; Vila, Greisa; Strunk, Guido; Clodi, Martin; Resl, Michael; Brath, Helmut; Prager, Rudolf; Luger, Anton; Pacher, Richard; Hülsmann, Martin Journal: Clinical chemistry Issue: Volume 62:Number 12(2016) Page Start: 1612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. Issue 3 (28th June 2021) Authors: Drexel, Heinz; Pocock, Stuart J; Lewis, Basil S; Saely, Christoph H; Kaski, Juan Carlos; Rosano, Giuseppe M C; Tautermann, Gerda; Huber, Kurt; Dopheide, Joern F; Mader, Arthur; Niessner, Alexander; Savarese, Gianluigi; Schmidt, Thomas A; Semb, Anne Grete; Tamargo, Juan; Wassmann, Sven; Clodi, Mar... Journal: European heart journal Issue: Volume 8:Issue 3(2022) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022) Authors: Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert; Hayee, Bu'hussain; Panaccione, Remo; Kim, Hyun-Soo; Reinisch, Walter; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Tang, Meina Tao; Schreiber, Stefan; Aboo, Nazimuddin; ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 2(2022) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022) Authors: Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J; Aguilar, Humberto; Ah... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 2(2022) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission. Issue 2 (4th December 2020) Authors: Sourij, Harald; Aziz, Faisal; Bräuer, Alexander; Ciardi, Christian; Clodi, Martin; Fasching, Peter; Karolyi, Mario; Kautzky‐Willer, Alexandra; Klammer, Carmen; Malle, Oliver; Oulhaj, Abderrahim; Pawelka, Erich; Peric, Slobodan; Ress, Claudia; Sourij, Caren; Stechemesser, Lars; Stingl, Harald; Stu... Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 2(2021) Page Start: 589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SUBCLINICAL KIDNEY INJURY IS CAUSED BY A MODERATE SINGLE INFLAMMATORY EVENT. Issue 1 (19th July 2022) Authors: Heinzl, Matthias Wolfgang; Resl, Michael; Klammer, Carmen; Fellinger, Paul; Schinagl, Lukas; Obendorf, Florian; Feldbauer, Roland; Pohlhammer, Johannes; Wagner, Thomas; Egger, Margot; Dieplinger, Benjamin; Clodi, Martin Journal: Shock Issue: Volume 58:Issue 1(2022) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers – A prospective cross‐over trial. Issue 24 (22nd November 2022) Authors: Pohlhammer, Johannes; Heinzl, Matthias Wolfgang; Klammer, Carmen; Feldbauer, Roland; Rosenberger, Klemens; Resl, Michael; Wagner, Thomas; Obendorf, Florian; Egger‐Salmhofer, Margot; Dieplinger, Benjamin; Clodi, Martin Journal: Journal of cellular and molecular medicine Issue: Volume 26:Issue 24(2022) Page Start: 5998 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles. Issue 19 (25th May 2016) Authors: Wurm, Raphael; Resl, Michael; Neuhold, Stephanie; Prager, Rudolf; Brath, Helmut; Francesconi, Claudia; Vila, Greisa; Strunk, Guido; Clodi, Martin; Luger, Anton; Pacher, Richard; Hülsmann, Martin Journal: Heart Issue: Volume 102:Issue 19(2016) Page Start: 1544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Association of endostatin with mortality in patients with chronic heart failure. (28th November 2013) Authors: Gouya, Ghazaleh; Siller‐Matula, Jolanta M.; Fritzer‐Szekeres, Monika; Neuhold, Stephanie; Storka, Angela; Neuhofer, Lisa M.; Clodi, Martin; Hülsmann, Martin; Pacher, Richard; Wolzt, Michael Journal: European journal of clinical investigation Issue: Volume 44:Number 2(2014:Feb.) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity. Issue 6 (December 2016) Authors: Schernthaner-Reiter, Marie Helene; Kasses, Dominik; Tugendsam, Christina; Riedl, Michaela; Peric, Slobodan; Prager, Gerhard; Krebs, Michael; Promintzer-Schifferl, Miriam; Clodi, Martin; Luger, Anton; Vila, Greisa Journal: European journal of endocrinology Issue: Volume 175:Issue 6(2016) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗